Entera Bio Income Statement (2017-2026) | ENTX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2017 Dec2018 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.11M0.14M0.17M0.07M0.04M0.01M0.01M0.06M0.04M0.08M0.04M
Cost of Revenue (Quarter)
0.10M0.07M0.14M0.05M0.03M0.01M0.01M0.05M0.04M0.08M0.04M
Gross Profit (Quarter)
0.01M0.07M0.03M0.01M0.01M0.00M0.01M0.01M
Operating items
Research & Development (Quarter)
1.23M1.77M2.65M1.69M1.39M1.41M1.35M0.93M1.21M1.37M1.00M0.73M1.09M1.48M1.20M1.12M1.52M1.64M1.72M2.25M
Selling, General & Administrative (Quarter)
1.36M1.53M1.48M2.17M1.88M1.46M1.74M1.29M1.14M1.03M0.97M1.33M1.09M1.54M1.14M1.44M1.15M1.61M1.32M1.29M
Other Operating Expenses (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M
Operating Expenses (Quarter)
2.58M3.29M4.12M3.85M3.26M2.87M3.07M2.21M2.33M2.39M1.96M2.06M2.17M3.02M2.34M2.56M2.67M3.26M3.04M3.54M
Operating Income (Quarter)
-2.57M-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.00M-2.38M-2.56M-2.70M-3.30M-3.03M-3.54M
EBIT (Quarter)
-2.57M-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.00M-2.38M-2.56M-2.70M-3.30M-3.03M-3.54M
Non-operating items
Non Operating Income (Quarter)
-0.02M-0.01M-0.03M0.04M0.06M-0.01M-0.01M0.02M0.01M0.04M-0.03M0.04M0.02M-0.01M-0.00M0.01M0.06M0.03M0.03M
Net income details
EBT (Quarter)
-2.59M-3.23M-4.12M-3.79M-3.19M-2.87M-3.08M-2.19M-2.33M-2.35M-2.00M-2.06M-2.20M-3.02M-2.34M-2.56M-2.70M-3.30M-3.03M-3.54M
Tax Provisions (Quarter)
-0.02M-0.01M-0.01M-0.01M-0.00M0.19M-0.05M0.03M0.01M
Profit After Tax (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.02M-2.15M-3.02M-2.36M-2.57M-2.66M-3.20M-3.02M-3.50M
Income from Continuing Operations (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.20M-3.02M-2.36M-2.56M-2.70M-3.30M-3.03M-3.54M
Consolidated Net Income (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.20M-3.02M-2.36M-2.56M-2.70M-3.30M-3.03M-3.54M
Income towards Parent Company (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.20M-3.02M-2.36M-2.56M-2.70M-3.30M-3.03M-3.54M
Net Income towards Common Stockholders (Quarter)
-2.58M-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.20M-3.02M-2.36M-2.56M-2.70M-3.30M-3.03M-3.54M
Additional items
EPS (Basic) (Quarter)
0.100.110.150.130.110.110.100.080.080.080.070.050.060.080.060.060.060.070.070.07
EPS (Weighted Average and Diluted) (Quarter)
0.100.110.150.130.110.110.100.080.080.080.070.050.060.080.060.060.060.070.070.07
Shares Outstanding (Weighted Average) (Quarter)
24.72M25.20M26.13M28.80M28.81M28.81M28.81M28.81M28.81M28.81M29.01M36.74M36.91M37.16M37.65M43.38M45.15M45.83M46.19M47.76M
Shares Outstanding (Diluted Average) (Quarter)
23.38M28.68M26.13M28.80M28.81M28.81M28.81M28.81M28.81M28.81M29.01M36.74M36.91M37.16M37.65M43.38M46.84M45.83M46.19M47.76M
EBITDA (Quarter)
-2.57M-3.22M-4.09M-3.83M-3.25M-2.87M-3.07M-2.21M-2.33M-2.39M-1.96M-2.06M-2.20M-3.00M-2.38M-2.56M-2.70M-3.30M-3.03M-3.54M
Tax Rate (Quarter)
0.66%0.40%0.36%0.18%0.13%-6.75%1.49%-1.23%-0.60%